Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.98
+0.08 (1.01%)
Dec 5, 2025, 4:00 PM EST - Market closed
Gyre Therapeutics Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Gyre Therapeutics stock ranges from a low of $16 to a high of $18. The average analyst price target of $17 forecasts a 113.03% increase in the stock price over the next year.
Price Target: $17.00 (+113.03%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 10, 2025.
Analyst Ratings
The average analyst rating for Gyre Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|
| Strong Buy | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +100.50% | Oct 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +125.56% | Aug 26, 2025 |
Financial Forecast
Revenue This Year
118.01M
from 105.76M
Increased by 11.59%
Revenue Next Year
149.06M
from 118.01M
Increased by 26.31%
EPS This Year
0.15
from 0.05
Increased by 218.24%
EPS Next Year
0.19
from 0.15
Increased by 24.45%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 122.4M | 207.9M | ||||
| Avg | 118.0M | 149.1M | ||||
| Low | 112.7M | 112.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 15.8% | 76.2% | ||||
| Avg | 11.6% | 26.3% | ||||
| Low | 6.6% | -5.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 0.23 | 0.45 | ||||
| Avg | 0.15 | 0.19 | ||||
| Low | 0.05 | 0.02 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 380.5% | 195.1% | ||||
| Avg | 218.2% | 24.4% | ||||
| Low | 1.9% | -87.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.